UK ADHD Statistics 2026: The Numbers You Need to Know

I rebuilt this page in July 2026, and I want to be straight with you about why.

I originally put it together because I kept seeing the same ADHD statistics thrown around on social media with no source, or with numbers years out of date. Then I went back and checked my own. Some of them did not hold up. A few had been repeated so often across coaching blogs and infographics that they looked authoritative, but when I traced them to the papers they were credited to, the papers said something different, or said nothing at all.

So this version is shorter than the last one, and deliberately so. Every figure below comes from a source I have read, linked at the bottom. Where a number does not exist, or where the official data genuinely cannot answer the question, I say so instead of filling the gap. If you are a journalist, researcher, student, or just someone trying to understand the landscape, I would rather give you fifteen numbers you can stand behind than fifty you cannot.

---

Prevalence: How Many People Have ADHD in the UK?

There is an important catch here, and almost nobody reporting this figure mentions it.

The 2.49 million is not a count of people. NHS England produces it by applying a fixed rate to the population: 3.5% of everyone aged 25 and over, and 5% of everyone aged 0 to 24. It is a modelled estimate of how many people probably have ADHD, built from the NICE prevalence rates. That makes it useful for planning services. It does not make it a measurement, and it cannot show a change in how common ADHD is over time, because the rate applied is held constant. If the estimate moves between publications, that is the population moving, not ADHD becoming more common.

You will also see this figure quoted as evidence of a huge rise in ADHD. It is not capable of showing that. NHS England's own methodology note is candid that the NICE estimates "are largely accepted however there is still debate within scientific and clinical literature."

---

The Diagnosis Gap

This is where UK data gets genuinely interesting, and where the honest numbers are more striking than the invented ones.

Set the estimated 3 to 5% prevalence against how many people actually have ADHD recorded in their health records. The ADHD Taskforce reports administrative prevalence, meaning ADHD as it appears in real UK clinical records:

Read those adult rows again. If roughly 3 to 4% of adults have ADHD, and it is recorded for 0.74% of men and 0.20% of women, then the overwhelming majority of adults with ADHD in this country do not have it on their record. For women the gap is widest by a distance.

You will very often see this expressed as "80% of adults with ADHD are undiagnosed". I used to quote a figure like that myself. I have taken it out, because NHS England states plainly that its data cannot tell you "the total number of people diagnosed with ADHD in England", and that "it is not possible to identify the number of referrals that result in a confirmed diagnosis of ADHD due to poor completeness of the diagnosis field." A precise undiagnosed percentage cannot be honestly derived from the available UK data. The administrative prevalence rows above are the real evidence, and they make the point without needing a made-up denominator.

The gap is not a sign of overdiagnosis. It reflects decades of underdiagnosis, especially in women, older adults, and people from minority ethnic backgrounds. I have written more on ADHD in women and on what late diagnosis actually feels like from the inside.

---

Waiting for an Assessment

Two things need saying about that headline referral number, because it is routinely misreported, including by me in the previous version of this page.

First, it is not a waiting list. NHS England counts open referrals in a category called neurodevelopmental conditions excluding autism, which also captures referrals for dyslexia, dyspraxia and Tourette syndrome. Its own guidance says the counts "are likely to overestimate ADHD referrals". Some of the people counted are not waiting for an assessment at all: they already have a private diagnosis and hold an open NHS referral so they can access medication.

Second, the word "up to" is doing real work. Nobody should present 803,658 as a firm number of people queuing for an ADHD assessment. It is a ceiling on a proxy measure.

What the data does support is the direction of travel, and it is stark. Open referrals rose from 735,157 in December 2025 to 803,658 in March 2026, and new monthly referrals were up 29.5% year on year. NHS England also cautions that figures from February 2025 onwards are not directly comparable with earlier months, because independent providers began submitting data.

The Taskforce is blunt that the current specialist model is not sustainable when demand so far exceeds capacity. If you are stuck in this system right now, my guide on what to do while you are on the NHS waiting list covers your practical options, and Right to Choose explains the route many people use to move faster.

On the regional waiting time table that used to sit here: I removed it. It gave confident year figures for each English region, and I could not trace any of them to a published source. The Taskforce ranges above are wide and untidy by comparison, but they are real.

Waiting is its own particular kind of hard, and it is a big part of what people bring to mentoring. Nothing I do speeds up an NHS assessment or replaces one. What it can do is stop the wait being dead time, by building the practical scaffolding for work, study and home life while the clinical process grinds on.

---

Treatment and Prescribing

Note what the NHSBSA figures are and are not. They count identified patients, not prescription items, which is the more meaningful measure of how many people are actually being treated. Adult prescribing grew far faster than children's, which fits everything else on this page about adult recognition catching up.

The 12-fold variation in treatment rates deserves more attention than it gets. Where you live in the UK has an enormous influence on whether you are treated at all.

I have deliberately not quoted a percentage for how many people benefit from medication. The previous version of this page claimed around 87%, credited to NICE NG87, and separately claimed response rates of 70% and 80 to 85% credited to Faraone and Glatt (2010). NG87 gives no such figure. Faraone and Glatt reported effect sizes, not response rates, finding larger effects for stimulants than non-stimulants. Those are different quantities, and turning one into the other invents a statistic. For what medication actually involves in the UK, including titration and monitoring, see ADHD medication in the UK explained, and for the ongoing supply problems, the ADHD medication shortage.

Medication decisions belong with your prescriber. Mentoring sits alongside that, never in place of it.

---

Co-occurring Conditions

ADHD rarely travels alone. The figures below are real, but read the source column carefully, because two of them are not UK data and one is about children.

The Kessler figures come from the US National Comorbidity Survey Replication. They are the most widely cited adult comorbidity numbers in existence and they are sound, but they are American, and I am not going to relabel them as UK statistics.

The autism rows previously said "50 to 70% of autistic people also meet ADHD criteria" and credited Leitner (2014). Leitner reports 30 to 50% of people with autism showing ADHD symptoms, mainly in children, with a very wide 37 to 85% range across clinic samples. I have corrected it to what the paper says. The width of that range is itself the finding: co-occurrence estimates depend heavily on who is being sampled.

For more on specific overlaps, see ADHD and anxiety, ADHD and depression, ADHD and sleep, ADHD and addiction, and what is AuDHD.

---

Genetics

That is one number where the old page had four, and the other three are gone because I could not trace them. Twin concordance rates and a "50% chance per child" figure were both credited to papers that, as far as I can establish, do not report them.

Seventy-six percent is high, and it is the honest headline: ADHD is one of the most heritable conditions in psychiatry. It is also why so many adults recognise themselves while sitting in their child's assessment. That is useful context, not a reason for alarm.

---

Economic and Social Cost

The £17 billion needs its provenance spelled out, because this is precisely the kind of figure that gets stripped of context and repeated as gospel.

Daley and colleagues (2019) is a Danish study. It compared 460 sibling pairs using national register data and found that each adult with ADHD cost €20,134 more per year than their own unaffected sibling, across health, social care, criminal justice, benefits, tax and income. The paper contains no UK figure at all. The £17 billion is the ADHD Taskforce applying that per-person cost to a UK population at 2.5% prevalence. It is a reasonable extrapolation from good data, and it is still an extrapolation. Quote it that way.

The previous version of this page said £3 to 5 billion and credited a US costing study. It also carried multipliers for unemployment, income reduction and workplace accidents that I could not trace to any of the sources named. They are gone.

If work is where ADHD is costing you personally, my guides on ADHD at work, reasonable adjustments and the Access to Work scheme are the practical end of this.

---

Rights and Support

No invented pound figures in this section. These are entitlements, and the amounts change, so check the official pages rather than trusting a number on a blog.

I previously listed an Access to Work maximum of around £68,000. The cap is uprated and I could not confirm the current year's figure from an official source, so rather than publish a number that might be wrong, I have linked to GOV.UK. For the detail on each of these, see is ADHD a disability?, PIP for ADHD, and the Equality Act and ADHD. Students should start with DSA support and ADHD at university.

---

What These Numbers Cannot Tell You

Worth being clear about the limits, because they matter as much as the figures:

• How many people in England have a confirmed ADHD diagnosis. NHS England says the diagnosis field is too incomplete to answer this.
• How many people are waiting specifically for an ADHD assessment. The referral count is a proxy that includes other neurodevelopmental conditions and people already diagnosed privately.
• How long the average wait is. No national average exists. Published ranges are wide and vary enormously by area.
• Whether ADHD is becoming more common. Rising referrals and prescribing show rising recognition and demand. The prevalence estimate cannot answer the underlying question, because it applies a fixed rate.
• Anything reliable about UK adult comorbidity. The best adult figures are American.

If a page quotes any of the above as a precise UK number, treat it with suspicion. That includes the earlier version of this one.

---

Key Sources

Every figure above traces to one of these. All were read before being cited.

• NHS England ADHD Management Information, May 2026 and the supporting methodology
• Report of the independent ADHD Taskforce, Part 1, NHS England
• NHSBSA: Medicines used in mental health, England, 2015/16 to 2024/25
• NICE NG87: ADHD diagnosis and management
• Community Pharmacy England on the 2026/27 prescription charge
• Faraone and colleagues (2005), Molecular genetics of ADHD, Biological Psychiatry 57(11)
• Kessler and colleagues (2006), adult ADHD in the United States, American Journal of Psychiatry 163(4):716-723
• Leitner (2014), co-occurrence of autism and ADHD in children, Frontiers in Human Neuroscience 8:268
• Bijlenga and colleagues (2019), the circadian system in ADHD, Attention Deficit and Hyperactivity Disorders 11(1):5-19
• Daley and colleagues (2019), economic burden of adult ADHD, European Psychiatry 61:41-48

Figures the previous version carried that I removed, because I could not trace them to the source they were credited to: an 80% undiagnosed rate, 120,000 to 200,000 UK adults formally diagnosed, a 20-fold rise in prevalence since 2000, a regional waiting time table, average waits by nation and route, 1.8 million annual prescriptions, an 800% rise in adult prescribing, an 87% medication benefit rate, response rates of 70% and 80 to 85%, 250,000 people affected by shortages, a £3 to 5 billion UK cost, unemployment and income multipliers, a workplace accident figure, twin concordance and per-child inheritance risks, university prevalence and completion figures, and several comorbidity upper bounds. If you have a primary source for any of them, I would genuinely like to see it.

---

Behind Every Number